SpringWorks Therapeutics, Inc. (SWTX) Cash Flow Quarterly - Discounting Cash Flows
SWTX
SpringWorks Therapeutics, Inc.
SWTX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
Report Filing: 2025-05-09 2025-05-09 2025-02-20 2024-11-12 2024-08-07 2024-05-02 2024-02-27
1234
Net Income/Starting Line -253.9 -83.19 -77.3 -53.53 -39.92 -87.39 -94.32
1234
Cash From Operating Activities -165.4 -68.76 -29.5 -25.38 -41.79 -78.93 -62.7
1234
Depreciation and Amortization 3.84 1.1 1.02 0.878 0.844 0.729 0.538
1234
Deferred Income Tax 0 0 0 0 0 0 1.83
1234
Stock Based Compensation 108.6 29.95 26.47 25.96 26.25 30.46 25.07
1234
Other Non-Cash Items -43.04 7.12 1.65 -54.03 2.22 1.43 0.477
1234
Changes in Working Capital 19.08 -23.74 18.66 55.34 -31.18 -24.16 3.7
1234
Accounts Receivable -24.82 5.89 -13.27 -8.47 -8.97 -9.6 -5.93
1234
Inventory -7.2 -2.21 -0.386 -2.11 -2.5 -2.11 -3.1
1234
Accounts Payable 7.85 2.86 2.66 1.58 0.745 -0.385 2.06
1234
Deferred Revenue -13.27 -30.29 29.65 7.82 -20.45 -12.06 1.64
1234
Other Working Capital 56.52 0 0 56.52 0 0 9.03
1234
Cash From Investing Activities 116.5 73.39 14.14 28.65 0.289 21.46 -159.2
1234
Investments in Property Plant and Equipment -8.9 -0.03 -6.05 9.4 -12.22 -0.577 2.3
1234
Payments for Acquisitions 8.23 0 0 8.23 0 -8.23 -2.3
1234
Purchases of Securities -203.2 0 -80.84 -36.79 -85.59 -73.64 -266.4
1234
Sales and Maturities of Investments 348.1 73.42 101 75.52 98.1 103.9 104.9
1234
Other Investing Activities -27.72 0 0 -27.72 0 0 2.3
1234
Cash From Financing Activities -5.29 -10.61 0.653 1.29 3.37 -0.552 299.1
1234
Debt Repayment 0 0 0 0 0 0 0
1234
Common Stock Issued 0 0 0 0 0 0 299.3
1234
Common Stock Repurchased -14.81 -12.87 -0.523 -0.499 -0.919 -6.5 -0.253
1234
Dividends Paid 0 0 0 0 0 0 0
1234
Other Financing Activities 9.52 2.26 1.18 1.79 4.29 5.95 0.024
1234
Effect of Forex Changes on Cash 0 0 0 0 0 0 0
1234
Net Change in Cash -15.5 -5.97 -14.7 4.56 -38.13 -58.02 77.16
1234
Cash at Beginning of Period 79.9 70.38 85.08 79.9 118 176.1 99.5
1234
Cash at End of Period 64.4 64.4 70.38 85.08 79.9 118 176.7
1234
Free Cash Flow -174.3 -68.79 -35.55 -15.98 -54.02 -79.51 -60.4
1234
Operating Cash Flow -165.4 -68.76 -29.5 -25.38 -41.79 -78.93 -62.7
1234
Capital Expenditure -8.9 -0.03 -6.05 9.4 -12.22 -0.577 2.3
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program